Spasticity: Clinical Trials

7 trials for Spasticity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed, 2 terminated. 7 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Recruiting 3, Completed 2, Terminated 2
Phase 24Recruiting 2, Completed 1, Terminated 1

Follow Spasticity: new trials by email Literature Review of Spasticity trials Research Report on Spasticity

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Use of Photobiomodulation in the Treatment of Spasticity After Stroke.
Photobiomodulation Therapy, Placebo PBM, Standard Multidisciplinary Rehabilitation Program for Spasticity - Stroke, Spasticity
Phase 1 / Phase 2RecruitingUniversity of Nove de Julho422026-08-282026-09-01
Shockwave for Elbow and Wrist Spasticity in People With Spinal Cord Injury
Focused extracorporeal shockwave therapy - Spinal Cord Injury, Spasticity
Phase 1RecruitingKessler Foundation122026-03-062026-10-22
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
Corabotase, Placebo, Dysport - Spasticity
Phase 1 / Phase 2RecruitingIpsen2402021-04-292026-07-28
Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT
shock waves, Botulinum Toxin Type A - Spasticity, Cerebral Palsy
Phase 1CompletedXavi Vidal Novellas702014-09-012017-03-13
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
baclofen - Spasticity, Cerebral Palsy
Phase 1 / Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)612008-11-012011-12-06
One Year Extension Study To Protocol C2/5/TZ:MS-05
sublingual tizanidine 12 mg - Spasticity, Multiple Sclerosis
Phase 1 / Phase 2TerminatedTeva GTC102008-01-012009-02-19
Botox vs. Baclofen for Upper Limb Spasticity
intramuscular Botox versus oral baclofen - Spasticity
Phase 1TerminatedVanderbilt University82006-02-012012-01-20

Narrower conditions

Muscle Spasticity (7)  ·  Cerebral Palsy (2)  ·  Brain Injuries, Traumatic (1)  ·  Fatigue (1)  ·  Multiple Sclerosis (1)  ·  Spinal Cord Injuries (1)  ·  Stroke (1)

Broader conditions

Muscle Hypertonia (7)  ·  Muscular Diseases (7)  ·  Musculoskeletal Diseases (7)  ·  Nervous System Diseases (7)  ·  Neurologic Manifestations (7)  ·  Neuromuscular Manifestations (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Signs and Symptoms (7)  ·  Central Nervous System Diseases (5)  ·  Brain Diseases (4)  ·  Brain Damage, Chronic (2)  ·  Trauma, Nervous System (2)  ·  Wounds and Injuries (2)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)

Interventions

Baclofen (1)  ·  Botulinum Toxins, Type A (1)  ·  Low-Level Light Therapy (1)  ·  abobotulinumtoxinA (1)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Ipsen (1)  ·  Kessler Foundation (1)  ·  Teva GTC (1)  ·  University of Nove de Julho (1)  ·  Vanderbilt University (1)  ·  Xavi Vidal Novellas (1)

Countries

United States (4)  ·  Spain (2)  ·  Austria (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)  ·  Portugal (1)  ·  Russia (1)

Top investigators

Arnon Karni, MD (1)  ·  Janice Brunstrom, MD (1)  ·  P. David Charles, MD (1)  ·  Richard Stevenson, MD (1)  ·  Vidal Novellas (1)

Results publications

PMID 24607242, PMID 28867665